Bullfrog AI (BFRG) Competitors $1.50 -0.01 (-0.66%) Closing price 04:00 PM EasternExtended Trading$1.52 +0.01 (+1.00%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. PDSB, ANVS, ANL, GANX, NRXP, ATRA, KRON, CELU, VTVT, and ARTVShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include PDS Biotechnology (PDSB), Annovis Bio (ANVS), Adlai Nortye (ANL), Gain Therapeutics (GANX), NRx Pharmaceuticals (NRXP), Atara Biotherapeutics (ATRA), Kronos Bio (KRON), Celularity (CELU), vTv Therapeutics (VTVT), and Artiva Biotherapeutics (ARTV). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Its Competitors PDS Biotechnology Annovis Bio Adlai Nortye Gain Therapeutics NRx Pharmaceuticals Atara Biotherapeutics Kronos Bio Celularity vTv Therapeutics Artiva Biotherapeutics Bullfrog AI (NASDAQ:BFRG) and PDS Biotechnology (NASDAQ:PDSB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Do institutionals and insiders believe in BFRG or PDSB? 1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 26.8% of PDS Biotechnology shares are held by institutional investors. 33.9% of Bullfrog AI shares are held by company insiders. Comparatively, 9.2% of PDS Biotechnology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor BFRG or PDSB? In the previous week, Bullfrog AI had 3 more articles in the media than PDS Biotechnology. MarketBeat recorded 3 mentions for Bullfrog AI and 0 mentions for PDS Biotechnology. Bullfrog AI's average media sentiment score of 0.09 beat PDS Biotechnology's score of -0.40 indicating that Bullfrog AI is being referred to more favorably in the media. Company Overall Sentiment Bullfrog AI Neutral PDS Biotechnology Neutral Do analysts prefer BFRG or PDSB? PDS Biotechnology has a consensus price target of $9.00, indicating a potential upside of 682.61%. Given PDS Biotechnology's stronger consensus rating and higher probable upside, analysts plainly believe PDS Biotechnology is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PDS Biotechnology 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has higher valuation & earnings, BFRG or PDSB? Bullfrog AI has higher revenue and earnings than PDS Biotechnology. Bullfrog AI is trading at a lower price-to-earnings ratio than PDS Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBullfrog AI$60K235.50-$6.99M-$0.81-1.85PDS BiotechnologyN/AN/A-$37.61M-$0.94-1.22 Is BFRG or PDSB more profitable? PDS Biotechnology's return on equity of -150.59% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Bullfrog AIN/A -163.23% -139.94% PDS Biotechnology N/A -150.59%-69.15% Which has more risk & volatility, BFRG or PDSB? Bullfrog AI has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, PDS Biotechnology has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. SummaryPDS Biotechnology beats Bullfrog AI on 9 of the 15 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.22M$2.02B$5.52B$9.41BDividend YieldN/AN/A4.01%4.05%P/E Ratio-1.8529.1418.7818.43Price / Sales235.5015.78446.2599.61Price / CashN/A52.8724.9928.17Price / Book2.638.468.145.70Net Income-$6.99M-$63.59M$3.24B$257.84M7 Day Performance-0.66%0.50%1.12%1.87%1 Month Performance-9.09%10.44%8.39%13.28%1 Year Performance-39.27%8.31%34.01%19.15% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.5938 of 5 stars$1.50-0.7%N/A-38.9%$14.22M$60K-1.854High Trading VolumePDSBPDS Biotechnology1.1668 of 5 stars$1.23-0.8%$9.00+631.7%-70.3%$56.22MN/A-1.3120ANVSAnnovis Bio1.6147 of 5 stars$2.87+5.7%$18.00+528.3%-76.5%$55.84MN/A-1.333ANLAdlai Nortye1.8518 of 5 stars$1.51-6.2%$9.00+496.0%-55.3%$55.72M$5M0.00127Gap UpGANXGain Therapeutics2.3266 of 5 stars$1.86+7.5%$8.20+340.9%+31.0%$55.71M$50K-2.1620NRXPNRx Pharmaceuticals2.3573 of 5 stars$3.21flat$28.50+787.9%+26.2%$55.50MN/A-1.602ATRAAtara Biotherapeutics4.2314 of 5 stars$9.30+0.8%$17.75+90.9%-9.2%$55.44M$199.73M-2.50330News CoverageInsider TradeGap UpKRONKronos BioN/A$0.88+1.5%$1.63+84.7%-29.6%$53.72M$9.85M-0.82100CELUCelularity0.0307 of 5 stars$2.24+6.2%N/A+0.3%$53.65M$54.22M-0.85220VTVTvTv Therapeutics1.569 of 5 stars$16.71-1.8%$35.50+112.4%-17.8%$53.31M$1.02M-5.559Positive NewsGap UpARTVArtiva Biotherapeutics2.6243 of 5 stars$2.18+6.9%$17.80+716.5%N/A$53.11M$250K0.0081News Coverage Related Companies and Tools Related Companies PDS Biotechnology Competitors Annovis Bio Competitors Adlai Nortye Competitors Gain Therapeutics Competitors NRx Pharmaceuticals Competitors Atara Biotherapeutics Competitors Kronos Bio Competitors Celularity Competitors vTv Therapeutics Competitors Artiva Biotherapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
